Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Uremia D014511 33 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Adenocarcinoma D000230 166 associated lipids
Ovarian Neoplasms D010051 10 associated lipids
Pain D010146 64 associated lipids
Contusions D003288 3 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Wounds and Injuries D014947 20 associated lipids
Pleurisy D010998 20 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Cattle Diseases D002418 24 associated lipids
Fatty Liver D005234 48 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Gastritis D005756 27 associated lipids
Heart Failure D006333 36 associated lipids
Pulmonary Edema D011654 23 associated lipids
Pulmonary Embolism D011655 5 associated lipids
Coronary Disease D003327 70 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Hypersensitivity D006967 22 associated lipids
Hypothyroidism D007037 32 associated lipids
Rhinitis D012220 10 associated lipids
Hypercapnia D006935 5 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Pain, Postoperative D010149 13 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Ward PS et al. Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin-1. 1991 Br. J. Pharmacol. pmid:1933130
Carmo LG et al. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor. 1985 Br. J. Pharmacol. pmid:2994786
Conroy DM et al. Effects of vasoactive intestinal peptide, helodermin and galanin on responses of guinea-pig lung parenchyma to histamine, acetylcholine and leukotriene D4. 1991 Br. J. Pharmacol. pmid:1725762
Juan H et al. Effect of exogenous 5,8,11,14,17-eicosapentaenoic acid on cardiac anaphylaxis. 1987 Br. J. Pharmacol. pmid:2881590
Bakhle YS et al. Differential release of eicosanoids by bradykinin, arachidonic acid and calcium ionophore A23187 in guinea-pig isolated perfused lung. 1985 Br. J. Pharmacol. pmid:2996675
Randon J et al. Blockade by methylation inhibitors of the anaphylactic response of guinea-pig lung strips. 1987 Br. J. Pharmacol. pmid:2447992
Wainwright CL et al. NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs. 2002 Br. J. Pharmacol. pmid:11959790
Provost P et al. Platelets, neutrophils, and vasoconstriction after arterial injury by angioplasty in pigs: effects of MK-886, a leukotriene biosynthesis inhibitor. 1998 Br. J. Pharmacol. pmid:9489613
Hugli TE and Marceau F Effects of the C5a anaphylatoxin and its relationship to cyclo-oxygenase metabolites in rabbit vascular strips. 1985 Br. J. Pharmacol. pmid:3921089
Giembycz MA et al. Leukotriene D4 receptors are not negatively coupled to adenylyl cyclase in guinea-pig lung parenchyma. 1993 Br. J. Pharmacol. pmid:8385538
Zhang BL and Sassard J Eicosanoid-dependence of responses of pre- but not postglomerular vessels to noradrenaline in rat isolated kidneys. 1993 Br. J. Pharmacol. pmid:8220883
Desquand S et al. Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection. 1991 Br. J. Pharmacol. pmid:1285397
De La Cruz JP et al. Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes. 1999 Br. J. Pharmacol. pmid:10602334
Ritter JM Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor. 1984 Br. J. Pharmacol. pmid:6386089
Gordon D et al. Selective inhibition of thromboxane biosynthesis in human blood mononuclear cells and the effects of mitogen-stimulated lymphocyte proliferation. 1981 Br. J. Pharmacol. pmid:7317694
Dirig DM and Yaksh TL In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin. 1999 Br. J. Pharmacol. pmid:10217526
Ochi T and Goto T Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis. 2002 Br. J. Pharmacol. pmid:11834626
Sheu JR et al. Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies. 2004 Br. J. Pharmacol. pmid:15289295
Giuliano F and Warner TD Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. 1999 Br. J. Pharmacol. pmid:10372826
Failli P et al. Effect of some cyclooxygenase inhibitors on the increase in guanosine 3':5'-cyclic monophosphate induced by NO-donors in human whole platelets. 1998 Br. J. Pharmacol. pmid:9579743
Franconi F et al. Further insights into the anti-aggregating activity of NMDA in human platelets. 1998 Br. J. Pharmacol. pmid:9630340
Burka JF and Garland LG A possible modulatory role for prostacyclin (PGI2) INIgGa-induced release of slow-reacting substance of anaphylaxis in rats. 1977 Br. J. Pharmacol. pmid:339980
Matz RL et al. Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. 2000 Br. J. Pharmacol. pmid:10991924
Cano JP et al. Molsidomine prevents post-ischaemic ventricular fibrillation in dogs. 1986 Br. J. Pharmacol. pmid:3755634
Higgs GA et al. The source of thromboxane and prostaglandins in experimental inflammation. 1983 Br. J. Pharmacol. pmid:6652359
Rho MC et al. Activation of rabbit platelets by Ca2+ influx and thromboxane A2 release in an external Ca(2+)-dependent manner by zooxanthellatoxin-A, a novel polyol. 1995 Br. J. Pharmacol. pmid:7582454
Sakai H et al. E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon. 2002 Br. J. Pharmacol. pmid:12023941
De Kimpe SJ et al. Bovine polymorphonuclear leukocytes increase sensitivity to noradrenaline in isolated mesenteric arteries. 1992 Br. J. Pharmacol. pmid:1628145
Sheu JR et al. The antiplatelet activity of PMC, a potent alpha-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase. 1999 Br. J. Pharmacol. pmid:10455267
Yin K et al. Study of mechanisms of glucocorticoid hypertension in rats: endothelial related changes and their amelioration by dietary fish oils. 1992 Br. J. Pharmacol. pmid:1393269
Jiménez R et al. Involvement of thromboxane A2 in the endothelium-dependent contractions induced by myricetin in rat isolated aorta. 1999 Br. J. Pharmacol. pmid:10455307
Mallarkey G and Smith GM In vivo platelet aggregation in the rat: dependence on extracellular divalent cation and inhibition by nonsteroidal anti-inflammatory drugs. 1984 Br. J. Pharmacol. pmid:6423018
Boukili MA et al. Pharmacological modulation of the effects of N-formyl-L-methionyl-L-leucyl-L-phenylalanine in guinea-pigs: involvement of the arachidonic acid cascade. 1986 Br. J. Pharmacol. pmid:3096407
Chu ZM and Beilin LJ Mechanisms of vasodilatation in pregnancy: studies of the role of prostaglandins and nitric-oxide in changes of vascular reactivity in the in situ blood perfused mesentery of pregnant rats. 1993 Br. J. Pharmacol. pmid:8358537
Riendeau D et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. 1997 Br. J. Pharmacol. pmid:9146894
Yeh CH et al. Pharmacological characterization and antithrombotic effect of agkistin, a platelet glycoprotein Ib antagonist. 2001 Br. J. Pharmacol. pmid:11181425
Lees P et al. Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin. 1987 Sep-Oct Br. Vet. J. pmid:3119142
Delatour P et al. Pharmacodynamics and chiral pharmacokinetics of carprofen in calves. 1996 Br. Vet. J. pmid:8680841
McKellar QA et al. Serum thromboxane generation by platelets in several domestic animal species. 1990 Sep-Oct Br. Vet. J. pmid:2224484
Taylor PM et al. Flunixin in the cat: a pharmacodynamic, pharmacokinetic and toxicological study. 1994 May-Jun Br. Vet. J. pmid:8044665
Lees P and Taylor PM Pharmacodynamics and pharmacokinetics of flunixin in the cat. 1991 Jul-Aug Br. Vet. J. pmid:1913126
Nobutoki T et al. Fluctuating hearing loss, episodic headache, and stroke with platelet hyperaggregability: coexistence of auditory neuropathy and cochlear hearing loss. 2006 Brain Dev. pmid:16168600
Patel PM et al. Differential temperature sensitivity of ischemia-induced glutamate release and eicosanoid production in rats. 1994 Brain Res. pmid:7953685
Cach R et al. Microvascular spasm is mediated by vasopressin fibers in the rat hippocampal slice. 1989 Brain Res. pmid:2706515
Busija DW et al. Acetylcholine dramatically increases prostanoid synthesis in piglet parietal cortex. 1988 Brain Res. pmid:3359178
Petroni A et al. Effects of hypoxia and recovery on brain eicosanoids and carbohydrate metabolites in rat brain cortex. 1987 Brain Res. pmid:3607494
Hynes N et al. Leukotrienes in brain: natural occurrence and induced changes. 1991 Brain Res. pmid:1933275
Cach R et al. Blood-borne factors regulating microvascular constriction in the rat hippocampal slice. 1987 Brain Res. pmid:3620912
Hartung HP et al. Recombinant interleukin-1 beta stimulates eicosanoid production in rat primary culture astrocytes. 1989 Brain Res. pmid:2501001
Faden AI et al. Effects of BW755C, a mixed cyclo-oxygenase-lipoxygenase inhibitor, following traumatic spinal cord injury in rats. 1988 Brain Res. pmid:3143469
Seregi A et al. Decreased levels of brain cyclo-oxygenase products as a possible cause of increased seizure susceptibility in convulsion-prone gerbils. 1984 Brain Res. pmid:6430471
Pettigrew LC et al. Delayed elevation of platelet activating factor in ischemic hippocampus. 1995 Brain Res. pmid:8590061
Constable AL et al. Production of prostanoids by Lewis rat Schwann cells in vitro. 1994 Brain Res. pmid:8173981
Andrus PK et al. Effects of the lipid peroxidation inhibitor tirilazad mesylate (U-74006F) on gerbil brain eicosanoid levels following ischemia and reperfusion. 1994 Brain Res. pmid:7820653
Ahmad M et al. Prolonged opportunity for neuroprotection in experimental stroke with selective blockade of cyclooxygenase-2 activity. 2009 Brain Res. pmid:19446533
Aïd S and Bosetti F Gene expression of cyclooxygenase-1 and Ca(2+)-independent phospholipase A(2) is altered in rat hippocampus during normal aging. 2007 Brain Res. Bull. pmid:17499644
Tuppo EE et al. Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease. 2001 Brain Res. Bull. pmid:11397549
Akarsu ES et al. Effect of ciliary neurotrophic factor on body temperature and cerebrospinal fluid prostanoids in the cat. 1998 Brain Res. Bull. pmid:9434196
Petroni A et al. Eicosanoid and inositol phosphate response to platelet-activating factor (PAF) and to a PAF antagonist in rat astroglial cells. 1994 Brain Res. Dev. Brain Res. pmid:8026072
Petrikova M et al. Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets. 2005 Bratisl Lek Listy pmid:15869009
Gajdos M et al. [The effect of monotherapy with ciprofibrate and in combination with acetylsalicylic acid on the spectrum of lipids, thromboxane and fibrinogen in patients with atherosclerosis and hyperlipoproteinemia]. 1999 Bratisl Lek Listy pmid:10645034
Kasjanovová D and Baláz V [Functional status of thrombocytes in men of various age groups]. 1990 Bratisl Lek Listy pmid:2224554
Rajec J et al. Biochemical evaluation of the antiplatelet effect of aspirin in patients at different levels of cardiovascular risk. 2008 Bratisl Lek Listy pmid:18814431
Kasjanovová D [Functional status of thrombocytes in men and women in younger age groups]. 1993 Bratisl Lek Listy pmid:8004501
Röth E Effect of Ca-antagonists, beta-blockers and antioxidant during reperfusion period. 1991 Mar-Apr Bratisl Lek Listy pmid:2029661
Lamy M et al. Biochemical pathways of acute lung injury. 1985 May-Jun Bull Eur Physiopathol Respir pmid:3873973
Sakanishi N et al. Thromboxane A2 and hemodynamic-biochemical parameters in canine endotoxin shock. 1983 Bull. Tokyo Med. Dent. Univ. pmid:6580966
Huang YS et al. Roles of thromboxane and its inhibitor anisodamine in burn shock. 1990 Burns pmid:2257065
Yregård L et al. Influence of local anaesthetics on inflammatory activity postburn. 2003 Burns pmid:12781610
Huang YS et al. Serial experimental and clinical studies on the pathogenesis of multiple organ dysfunction syndrome (MODS) in severe burns. 1998 Burns pmid:9915670
Huang YS et al. Effect of smoke inhalation injury on thromboxane levels and platelet counts. 1988 Burns Incl Therm Inj pmid:3250716
Girotti MJ et al. Comparison of regional pulmonary perfusion in lobar pneumonia during high frequency and conventional mechanical ventilation in sheep. 1987 Can J Anaesth pmid:3581395
Licker M et al. Chronic angiotensin converting inhibition does not influence renal hemodynamic and function during cardiac surgery. 1999 Can J Anaesth pmid:10442956
Byrick RJ et al. Corticosteroids do not inhibit acute pulmonary response to fat embolism. 1990 Can J Anaesth pmid:2193732
Byrick RJ et al. Prostanoid production and pulmonary hypertension after fat embolism are not modified by methylprednisolone. 1991 Can J Anaesth pmid:1934222
Landymore RW et al. Correlation between the effects of aspirin and dipyridamole on platelet function and prevention of intimal hyperplasia in autologous vein grafts. 1988 Jan-Feb Can J Cardiol pmid:3359354
Gerrard JM et al. The structured interview elicits a differential prostacyclin response in A and B behaviour types. 1991 Can J Cardiol pmid:2070285
Klein RC et al. Absence of differential inhibition of thromboxane A2 and prostacyclin by low and high dose aspirin in coronary artery disease. 1987 Can J Cardiol pmid:3322532
Shizukuda Y et al. Effect of prednisolone on myocardial infarct healing: characteristics and comparison with indomethacin. 1991 Can J Cardiol pmid:1768984
Chou TZ et al. Effect of felodipine-ER on blood pressure, platelet function, and rheological properties in hypertension. 1993 Can J Cardiol pmid:8394193
Moreno A et al. Prostacyclin-thromboxane balance and retinal vascular pattern in rats with experimentally induced diabetes. 1995 Can. J. Ophthalmol. pmid:7627895
Tosaki A et al. Effect of cicletanine on reperfusion-induced arrhythmias and its relation to 6-keto-PGF1 alpha and thromboxane B2 release. 1991 Can. J. Physiol. Pharmacol. pmid:2059911
Datar S et al. Effect of cyclooxygenase and thromboxane synthetase inhibition on furosemide-stimulated plasma renin activity. 1987 Can. J. Physiol. Pharmacol. pmid:3105853
Rodrigue ME et al. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats. 2005 Can. J. Physiol. Pharmacol. pmid:16049546
Gerrard JM Measurements of 6-keto-prostaglandin F1 alpha and thromboxane B2 in bleeding time blood: relation to bleeding and vascular disorders? 1989 Can. J. Physiol. Pharmacol. pmid:2688855
Kitamura R et al. Thiopental enhances human platelet aggregation by increasing arachidonic acid release. 2001 Can. J. Physiol. Pharmacol. pmid:11697744
Kaushal RD and Wilson TW Effect of furegrelate on renal plasma flow after angiotensin II infusion. 1990 Can. J. Physiol. Pharmacol. pmid:2328452
Liao CH et al. Antiplatelet effect of demethyldiisoeugenol. 1996 Can. J. Physiol. Pharmacol. pmid:9022830
Jancar S et al. Mechanism of action of platelet-activating factor on guinea-pig lung parenchyma strips. 1988 Can. J. Physiol. Pharmacol. pmid:3146431
Smith EF et al. Influence of thromboxane inhibition on the severity of myocardial ischemia in cats. 1980 Can. J. Physiol. Pharmacol. pmid:7378931
Jiang J et al. Endothelin-1 blockade prevents COX2 induction and TXA2 production in the fructose hypertensive rat. 2007 Mar-Apr Can. J. Physiol. Pharmacol. pmid:17612651
Carvalho C et al. Inhibition of airway hyperreactivity, edema, and lung cell infiltration by compound U-83836E in sensitized guinea pigs. 1998 Jul-Aug Can. J. Physiol. Pharmacol. pmid:10030451
Lewis K et al. Effect of neuropeptide Y on bradykinin-induced release of prostacyclin and thromboxane from guinea pig perfused lung. 1997 Can. J. Physiol. Pharmacol. pmid:9276148
Jenkins DK et al. Effects of albumin on fatty acid, protein, and eicosanoid levels in rat mesenteric arterial bed perfusions. 1988 Can. J. Physiol. Pharmacol. pmid:3167681
Gibb W et al. Cyclooxygenase products formed by primary cultures of cells from human chorion laeve: influence of steroids. 1988 Can. J. Physiol. Pharmacol. pmid:3167693
Riendeau D et al. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. 1997 Can. J. Physiol. Pharmacol. pmid:9365818
Jackman BR et al. Comparison of the effects of ketoprofen and flunixin meglumine on the in vitro response of equine peripheral blood monocytes to bacterial endotoxin. 1994 Can. J. Vet. Res. pmid:8004539
King JN The use of intradermal carrageenan in calves to estimate the dose of oxindanac, a nonsteroidal anti-inflammatory drug. 1993 Can. J. Vet. Res. pmid:8269358
Yamamura S et al. Prostaglandin levels of primary bone tumor tissues correlate with peritumoral edema demonstrated by magnetic resonance imaging. 1997 Cancer pmid:9010098
Klausner JM et al. Interleukin-2-induced lung permeability is mediated by leukotriene B4. 1990 Cancer pmid:2173970